AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Immutep Limited American Depositary Shares
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG002WD6TP4
3.20▲ 0.03 (0.95%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
3.17
Day's Range
3.10 – 3.23
52-Week Range
0.26 – 5.36
Volume
7,898
Avg Volume
139.8K
Share Statistics
Shares Outstanding
Employees
51
Exchange
XNAS
Listed
1988-01-01
Share count as of June 30, 2025

Immutep Limited American Depositary Shares (IMMP) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Immutep Limited American Depositary Shares (IMMP)
What is Immutep Limited American Depositary Shares's Market Cap?
Immutep Limited American Depositary Shares's Market Cap is $4.7B, based on as-reported figures from SEC (XBRL) filings.
What is Immutep Limited American Depositary Shares's Enterprise Value?
Immutep Limited American Depositary Shares's Enterprise Value is $4.6B, based on as-reported figures from SEC (XBRL) filings.
What is Immutep Limited American Depositary Shares's Price / Sales?
Immutep Limited American Depositary Shares's Price / Sales is 688.2×, based on as-reported figures from SEC (XBRL) filings.
What is Immutep Limited American Depositary Shares's EV / Revenue?
Immutep Limited American Depositary Shares's EV / Revenue is 681.6×, based on as-reported figures from SEC (XBRL) filings.
What is Immutep Limited American Depositary Shares's EV / EBITDA?
Immutep Limited American Depositary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Immutep Limited American Depositary Shares's Revenue (TTM)?
Immutep Limited American Depositary Shares's Revenue (TTM) is $6.8M, based on as-reported figures from SEC (XBRL) filings.
What is Immutep Limited American Depositary Shares's Net Income (TTM)?
Immutep Limited American Depositary Shares's Net Income (TTM) is -$40.4M, based on as-reported figures from SEC (XBRL) filings.
What is Immutep Limited American Depositary Shares's EBITDA?
Immutep Limited American Depositary Shares's EBITDA is -$38.8M, based on as-reported figures from SEC (XBRL) filings.
What is Immutep Limited American Depositary Shares's Diluted EPS (TTM)?
Immutep Limited American Depositary Shares's Diluted EPS (TTM) is -0.03, based on as-reported figures from SEC (XBRL) filings.
What is Immutep Limited American Depositary Shares's EBITDA Margin?
Immutep Limited American Depositary Shares's EBITDA Margin is -571.1%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · IMMPAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of AUD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2025Jun 30, 2024Jun 30, 2023Jun 30, 2022Jun 30, 2021Jun 30, 2020Jun 30, 2019Jun 30, 2018
Revenue
License revenue
Other income
Research material sales
Grant income
Net gain on foreign exchange
Fair value gain on financial assets
Net gain on fair value movement of warrants
Interest income
Miscellaneous
Total revenue and other income
Expenses
Research & development and intellectual property expenses
Corporate administrative expenses
Net loss on foreign exchange
Loss before income tax expense
Loss after income tax expense for the year
Loss for the year is attributable to:
Owners of Immutep Limited